These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6767222)

  • 1. Valproate in nonketotic hyperglycinemia.
    MacDermot K; Nelson W; Weinberg JA; Schulman JD
    Pediatrics; 1980 Mar; 65(3):624. PubMed ID: 6767222
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipropylacetate and hyperglycinemia.
    Similä S; von Wendt L; Linna SL; Saukkonen AL; Huhtaniemi I
    Neuropadiatrie; 1979 May; 10(2):158-60. PubMed ID: 386163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia.
    Morrison PF; Sankar R; Shields WD
    Pediatr Neurol; 2006 Nov; 35(5):356-8. PubMed ID: 17074608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.
    Viljoen J; Bergh JJ; Mienie LJ; Kotze HF; Terre'Blanche G
    Metab Brain Dis; 2012 Sep; 27(3):327-35. PubMed ID: 22350964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of nonketotic hyperglycinemia in patients treated with valproic acid.
    Korman SH
    Pediatr Neurol; 2007 Jul; 37(1):77. PubMed ID: 17628231
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course.
    Chiong MA; Procopis P; Carpenter K; Wilcken B
    Pediatr Neurol; 2007 Oct; 37(4):283-6. PubMed ID: 17903674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia.
    Deutsch SI; Rosse RB; Mastropaolo J
    Clin Neuropharmacol; 1998; 21(2):71-9. PubMed ID: 9579291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid.
    Mortensen PB; Kølvraa S; Christensen E
    Epilepsia; 1980 Dec; 21(6):563-9. PubMed ID: 6777152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonketotic hyperglycinemia in a neonate.
    Sehgal V; Ramji S
    Indian Pediatr; 1998 Mar; 35(3):278-81. PubMed ID: 9707887
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis.
    Applegarth DA; Toone JR
    Mol Genet Metab; 2001; 74(1-2):139-46. PubMed ID: 11592811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH).
    Toone JR; Applegarth DA; Coulter-Mackie MB; James ER
    Mol Genet Metab; 2001 Apr; 72(4):322-5. PubMed ID: 11286506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonketotic hyperglycinemia].
    Tada K; Kure S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):227-30. PubMed ID: 9590032
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonketotic hyperglycinemia in a newborn infant.
    Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
    Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tryptophan for the treatment of nonketotic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-D-aspartate receptor.
    Matsuo S; Inoue F; Takeuchi Y; Yoshioka H; Kinugasa A; Sawada T
    Pediatrics; 1995 Jan; 95(1):142-6. PubMed ID: 7770295
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening.
    Tan ES; Wiley V; Carpenter K; Wilcken B
    Mol Genet Metab; 2007 Apr; 90(4):446-8. PubMed ID: 17207649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia.
    Kure S; Kojima K; Ichinohe A; Maeda T; Kalmanchey R; Fekete G; Berg SZ; Filiano J; Aoki Y; Suzuki Y; Izumi T; Matsubara Y
    Ann Neurol; 2002 Nov; 52(5):643-6. PubMed ID: 12402263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of valproic acid and sodium valproate (author's transl)].
    Sorel L; Rucquoy-Ponsar M; Willems C; Diepart E; Harmant J
    Acta Neurol Belg; 1981; 81(5):283-90. PubMed ID: 6797226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia.
    Kure S; Kojima K; Kudo T; Kanno K; Aoki Y; Suzuki Y; Shinka T; Sakata Y; Narisawa K; Matsubara Y
    J Hum Genet; 2001; 46(7):378-84. PubMed ID: 11450847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-ketotic hyperglycinemia. Transient neonatal form].
    Vaquerizo J; Rincón P; Sánchez Alarcón J; Gómez Martín H; Alejo J; Cardesa JJ
    Rev Neurol; 1996 Mar; 24(127):293-5. PubMed ID: 8742393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate and hyperglycinaemia.
    Bartlett K
    Lancet; 1977 Oct; 2(8040):716. PubMed ID: 71523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.